Schlenk flask under an argon atmosphere. The resulting mixture
was then heated up to 100 ◦C and analyzed by GC. Pure samples of
the final products N-[(phenylamino)benzyl]acetamides (4) could
be obtained by filtering the crude mixtures on celite, concentrating
the filtrates under vacuum and eluting the resulting crude oils on
silica (gradient dichloromethane/methanol from 100:0 to 98:2).
Suzuki/amidation cascade reaction
Phenyl boronic acid (148 mg, 1.21 mmol), potassium fluoride
(188 mg, 3.23 mmol), Pd(dba)2 (12.5 mg, 0.0217 mmol) and
-
PtBu3H+ BF4 (8 mg, 0.0270 mmol) were inserted into a Schlenk
flask under an argon atmosphere. The system was then briefly
evacuated and backfilled with argon (3 cycles). At this point freshly
deoxygenated toluene (6 mL) was inserted into the Schlenk flask
under argon and the mixture was briefly stirred (5 seconds). Then
4-bromobenzylamine (1a) (1.08 mmol), ethyl acetate (3.60 mmol)
N-[4-(Phenylamino)benzyl]acetamide (4a, pale yellow solid).
dH (500 MHz; CDCl3; Me4Si) 7.26 (2H, dd, J 8 and 7.5), 7.14
(2H, d, J 8.5), 7.06 (2H, d, J 8), 7.01 (2H, d, J 7.5), 6.93 (1H,
t, J 7.5), 6.46 (1H, bs), 6.07 (1H, bs), 4.31 (2H, d, J 5.5) and
1.97 (3H, s); dC (125.7 MHz; CDCl3; Me4Si) 170.5, 143.4, 142.8,
130.7, 129.6, 129.2, 121.1, 118.0, 117.9, 43.527 and 23.4; m/z (EI)
240 (M+, 100%), 197 (29%) and 182 (92%); mp 103 ◦C (from
CH2Cl2/MeOH).
R
and 200 mg Novozym 435ꢀ were inserted into the Schlenk flask
under an argon atmosphere. The resulting mixture was then heated
up to 100 ◦C and analyzed by GC. A pure sample of the final
product N-[4-phenylbenzyl]acetamide (6a) could be obtained by
filtering the crude mixture on celite, concentrating the filtrate
under vacuum and eluting the resulting crude oil on silica (gradient
dichloromethane/methanol from 100:0 to 98:2).
N-[4-(2-Methylphenylamino)benzyl]acetamide (4b, yellow oil).
dH (500 MHz; CDCl3; Me4Si) 7.21 (2H, d, J 8), 7.15 (3H, m),
6.95 (1H, dd, J 8 and 6.5), 6.91 (2H, d, J 8), 5.92 (1H, bs), 4.34
(2H, d, J 5.5), 2.25 (3H, s) and 2.00 (3H, s); dC (125.7 MHz; CDCl3;
Me4Si) 170.1, 143.8, 141.2, 131.2, 130.1, 129.3, 128.9, 127.0, 122.5,
119.3, 117.6, 43.6, 23.5 and 18.1; m/z (EI) 254 (M+, 100%), 211
(26%) and 196 (81%).
N-[4-Phenylbenzyl]acetamide (6a; light brown solid). dH
(500 MHz; CDCl3; Me4Si) 7.57 (4H, m), 7.45 (2H, t, J 7.5),
7.36 (3H, m), 5.73 (1H, bs), 4.49 (2H, d, J 5.5) and 2.06 (3H,
s); dC (125.7 MHz; CDCl3; Me4Si) 170.3, 140.9, 140.8, 137.4,
129.0, 128.6, 127.7, 127.6, 127.3, 43.7 and 23.5; m/z (EI) 225
(M+, 100%) and 182 (66%); mp 182 ◦C (from CH2Cl2/MeOH;
lit.29 180–182 ◦C).
N-[4-(4-Methoxyphenylamino)benzyl]acetamide (4c, white
solid). dH (500 MHz; CDCl3; Me4Si) 7.12 (2H, d, J 8.5), 7.06
(2H, bs), 6.86 (4H, m), 5.78 (1H, bs), 4.33 (2H, bs), 3.80 (3H, s)
and 2.00 (3H, s); dC (125.7 MHz; CDCl3; Me4Si) 170.0, 155.7,
144.9, 135.7, 129.4, 122.5, 115.9, 114.9, 55.8, 43.6 and 23.5; m/z
(EI) 270 (M+, 100%), 255 (43%), 227 (11%) and 212 (40%); mp
121–123 ◦C (from CH2Cl2/MeOH).
Sonogashira/amidation cascade reaction
Caesium carbonate (560 mg, 1.72 mmol), 2-(ditertbutyl-
phosphino)biphenyl (22.5 mg, 0.0756 mmol), Pd(dba)2 (15.5 mg,
0.0270 mmol) were inserted into a Schlenk flask under an argon
atmosphere. The system was then briefly evacuated and backfilled
with argon (3 cycles). At this point freshly deoxygenated toluene
(6 mL) was inserted into the Schlenk flask under argon and the
mixture was briefly stirred (5 seconds). Then 4-bromobenzylamine
(1a) (1.08 mmol), phenylacetylene (1.51 mmol), methyl acetate
N-[4-(3-Nitrophenylamino)benzyl]acetamide (4d, red solid). dH
(500 MHz; CDCl3; Me4Si) 7.83 (1H, t, J 2), 7.70 (1 H, dd, J 8
and 2), 7.37 (1H, t, J 8), 7.27 (3H, m), 7.11 (2H, d, 8.5), 6.06
(1H, bs), 5.81 (1H, bs), 4.41 (2H, d, J 5.5) and 2.05 (3H, s);
dC (125.7 MHz; CDCl3; Me4Si) 170.1, 149.9, 145.2, 140.6, 133.2,
130.3, 129.6, 122.1, 120.3, 115.0, 110.4, 43.6 and 23.6; m/z (EI)
(M+, 100%), 268 (81%), 242 (46%) and 227 (66%); mp 158 ◦C
(from CH2Cl2/MeOH).
R
(3.60 mmol) and 200 mg Novozym 435ꢀ were inserted into the
Schlenk flask under an argon atmosphere. The resulting mixture
was then heated up to 100 ◦C and analyzed by GC. A pure sample
of the final product N-[4-(2-phenylethynyl)benzyl]acetamide (7a)
could be obtained by filtering the crude mixture on celite,
concentrating the filtrate under vacuum and eluting the resulting
crude oil on silica (gradient dichloromethane/methanol from
100:0 to 98:2).
N-[4-(3-Fluorophenylamino)benzyl]acetamide (4e, yellow oil).
dH (500 MHz; CDCl3; Me4Si) 7.17 (3H, m), 7.06 (2H, d, J 8.5), 6.74
(2H, m), 6.58 (1H, m), 5.92 (2H, bs), 4.35 (2H, d, J 5.7) and 2.01
(3H, s); dC (125.7 MHz; CDCl3; Me4Si) 170.2, 164.0 (d, J 244),
145.4 (d, J 11.8), 141.7, 131.8, 130.7 (d, J 9.7), 129.3, 119.3, 112.8,
107.2 (d, J 20.7), 103.7 (d, J 24.4), 43.5 and 23.5; dF (470.5 MHz;
CDCl3; CFCl3) -112.2; m/z (EI) 258 (M+, 100%), 215 (31%) and
200 (74%).
N-[4-(2-Phenylethynyl)benzyl]acetamide (7a; light brown solid).
dH (500 MHz; CDCl3; Me4Si) 7.53 (2H, m), 7.50 (2H, d, J 8.0),
7.35 (3H, m), 7.26 (2H, d, J 8.0), 5.81 (1H, bs), 4.45 (2H, d, J
6.0) and 2.04 (3H, s); dC (125.7 MHz; CDCl3; Me4Si) 170.1, 138.7,
132.1, 131.8, 128.6, 128.5, 128.0, 123.4, 122.8, 89.8, 89.2, 43.7 and
23.5; m/z (EI) 249 (M+, 100%), 206 (66%), 191 (30%) and 178
(31%); mp 156 ◦C (from CH2Cl2/MeOH).
N-[3-(Phenylamino)benzyl]acetamide (4f, pale yellow solid). dH
(500 MHz; CDCl3; Me4Si) 7.27 (2H, dd, J 8.5 and 7.5), 7.21 (1H,
t, J 7.5), 7.07 (2H, d, J 8.5), 6.99 (1H, d, J 8), 6.94 (2H, m), 6.81
(1H, d, J 7.5), 6.04 (1H, bs), 5.88 (1H, bs), 4.35 (2H, d, J 6) and
1.99 (3H, s); dC (125.7 MHz; CDCl3; Me4Si) 170.3, 143.9, 143.0,
139.8, 129.9, 129.6, 121.5, 120.2, 118.4, 117.0, 116.5, 43.968 and
23.465; m/z (EI) 240 (M+, 100%), 197 (58%) and 180 (20%); mp
135–137 ◦C (from CH2Cl2/MeOH).
Acknowledgements
The authors would like to acknowledge fruitful discussions with
Professor Roeland J.M. Nolte (University of Nijmegen) and
Professor Piet W.N.M. van Leeuwen (University of Amsterdam),
and NWO-ACTS and Synthon BV for financial support.
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 2926–2932 | 2931
©